Ali Behbahani is of CRISPR Therapeutics AG. Currently has a direct ownership of 256 shares of CRSP, which is worth approximately $12,902. The most recent transaction as insider was on Aug 13, 2020, when has been sold 57 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 256
0% 3M change
0% 12M change
Total Value Held $12,902

Ali Behbahani Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 13 2020
BUY
Other acquisition or disposition
-
57 Added 18.21%
256 Common Stock
May 14 2018
BUY
Other acquisition or disposition
-
199 Added 50.0%
199 Common Stock

Also insider at

RGLS
Regulus Therapeutics Inc. Healthcare
MRKR
Marker Therapeutics, Inc. Healthcare
BDTX
Black Diamond Therapeutics, Inc. Healthcare
OYST
Oyster Point Pharma, Inc. Healthcare
NKTX
Nkarta, Inc. Healthcare
GLUE
Monte Rosa Therapeutics, Inc. Healthcare
BHG
Bright Health Group Inc. Healthcare
CVRX
CVRx, Inc. Healthcare
ADAP
Adaptimmune Therapeutics PLC Healthcare
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
TRVI
Trevi Therapeutics, Inc. Healthcare
UTRS
MINERVA SURGICAL INC Healthcare
MTCR
Metacrine, Inc. Healthcare
AKUS
Akouos, Inc. Healthcare
ACLX
Arcellx, Inc. Healthcare
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
SVRA
Savara Inc Healthcare
FREQ
Frequency Therapeutics, Inc. Healthcare
MBX
MBX Biosciences, Inc.
AB

Ali Behbahani

Timonium, MD

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Track Activities on CRSP